Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder

NCT01059539 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01059539
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01059539 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Open-label Study of the Safety and Tolerability of Cariprazine in Patients With Bipolar I Disorder
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2010
Completion date
February 29, 2012
Enrollment
403 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder